From: Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
 | Tumor, N=249 | Capsule, N=80 | ||||
---|---|---|---|---|---|---|
Factor | Hazard Ratio | 95% CI | P | Hazard Ratio | 95% CI | P |
Nationality | Â | Â | Â | Â | Â | Â |
 Norwegian | 1.000 |  |  | 1.000 |  |  |
 Russian | 0.948 | 0.603-1.490 | 0.816 | 0.588 | 0.263-1.312 | 0.194 |
Tumor size | Â | Â | Â | Â | Â | Â |
 < 5 cm | 1.000 |  | 0.540* | 1.000 |  | 0.342* |
 5-10 cm | 1.103 | 0.687-1.770 | 0.685 | 0.888 | 0.376-2.099 |  |
 > 10 cm | 1.310 | 0.797-2.153 | 0.287 | 1.671 | 0.660-4.233 |  |
Malignancy grade FNCLCC | Â | Â | Â | Â | Â | Â |
 1 | 1.000 |  | 0.001* | 1.000 |  | 0.051* |
 2 | 1.997 | 1.129-3.531 | 0.017 | 1.402 | 0.383-5.137 | 0.610 |
 3 | 2.874 | 1.617-5.107 | <0.001 | 2.954 | 0.837-10.432 | 0.092 |
Metastasis at time of diagnosis | Â | Â | Â | Â | Â | Â |
 No | 1.000 |  |  | 1.000 |  |  |
 Yes | 2.842 | 1.855-4.354 | <0.001 | 2.101 | 0.901-4.898 | 0.086 |
Resection margins | Â | Â | Â | Â | Â | Â |
 Wide | 1.000 |  |  | 1.000 |  |  |
 Non-wide | 2.523 | 1.706-3.730 | <0.001 | 2.245 | 1.077-4-680 | 0.031 |
Ki67 | Â | Â | Â | Â | Â | Â |
 Low | 1.000 |  | 0.432* | 1.000 |  |  |
 Medium | 1.059 | 0.528-2.163 | 0.876 | - | - | - |
 High | 1.365 | 0.710-2.625 | 0.351 | 2.553 | 1.167-5.584 | 0.019 |
M-CSF | Â | Â | Â | Â | Â | Â |
 Low | 1.000 |  |  | NIA |  |  |
 High | 0.815 | 0.463-1.435 | 0.478 |  |  |  |
TGF-beta | Â | Â | Â | Â | Â | Â |
 Low | 1.000 |  |  | NIA |  |  |
 High | 0.682 | 0.247-1.881 | 0.460 |  |  |  |
M-CSF and TGF-beta | Â | Â | Â | Â | Â | Â |
 Low | 1.000 |  |  | NIA |  |  |
 High | 1.532 | 1.062-2.208 | 0.022 |  |  |  |